With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.
With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.
As per survey, 50% of the respondents said that medical devices they came across, did not have MRPs.
The list is intended to be the basis for policy action intended to prevent distributors, wholesalers, retailers and even hospitals from seeking exorbitant trade margins on products .
"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market," company said.
Bayer raised the objection against Natco’s brand launched under the name Regonat alleging infringement of its patent rights.
The deal was signed after a highly competitive bidding process that attracted some of the largest buyout PE funds, people aware told ET.
The deal is expected to be sealed at a valuation of $1 billion, after a highly competitive bid process that saw some of the largest buyout PE funds participate, people aware of the ongoing discussions told ET.
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore.
Bihar failed to spend even a third of Rs 88.5 crore given by the Centre in 2018-19 to upgrade its existing primary health centres (PHCs) and health sub-centres.
A consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.
"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capability," GSK Pharmaceuticals MD (India) A Vaidheesh told PTI.
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
Investigation finds condom cos may have colluded to overcharge govt by rigging bids.
Besides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second round of bidding,
Besides, the increase in chronic diseases, rising per capita income and resultant healthcare spend will also aid to its growth.
Founded in 2014 by Fernandes and Hamish Boyd (therapeutic clowns from Canada), the Auroville societyregistered MeDi Clown believes the FASMC is the first step to scale the model around this “distraction therapy”.
PE and pharma peers have been sounded out and a formal process is due to be launched, said sources.
Medanta, founded in 2009, operates super speciality hospitals and clinics.
After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
CTSI is part of Asia Healthcare Holdings (AHH), a healthcare operating platform founded by TPG Growth.
